LAVA Therapeutics N.V. (LVTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 4.99M | 0 | 0 | 6.99M | 353K | 53K | 5.14M | 1.22M | 2.64M | 15.26M | 468K | 1.02M | 1.07M | 2.1M | 1.08M | 1M | 1.76M |
| Revenue Growth % | - | - | -100% | 1313.6% | -100% | -100% | 471.24% | -86.63% | -99.65% | 998.08% | 19.77% | 147.65% | 628.45% | -56.67% | 2.2% | -39.58% | - | 62.35% | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 24.55M | 0 | 0 | 0 | 154K | 10K | 2.39M | 930K | 0 | 0 | 0 | 0 | 6.63M | 6.7M | 4.89M | 18.71M | 4.32M |
| COGS % of Revenue | - | - | - | 491.98% | - | - | - | 43.63% | 18.87% | 46.47% | 75.98% | - | - | - | - | 622.33% | 319.95% | 453.24% | 1871.2% | 245% |
| Gross Profit | 0 | 0 | 0 | -19.56M | 0 | 0 | 6.99M | 199K | 43K | 2.75M | 294K | 2.64M | 15.26M | 468K | 1.02M | -5.57M | -4.61M | -3.81M | -17.71M | -2.56M |
| Gross Margin % | - | - | - | -391.98% | - | - | 100% | 56.37% | 81.13% | 53.53% | 24.02% | 100% | 100% | 100% | 100% | -522.33% | -219.95% | -353.24% | -1771.2% | -145% |
| Gross Profit Growth % | - | - | -100% | -9929.15% | -100% | -100% | 2278.23% | -92.46% | -99.72% | 487.82% | -71.23% | 147.41% | 431.18% | 112.27% | 105.77% | -117.65% | - | -36.78% | -447.59% | - |
| Operating Expenses | 7.55M | 7.29M | 7.59M | -12.46M | 11.29M | 9.39M | 9.03M | 5.64M | 10.77M | 16.3M | 13.83M | 14.12M | 16.83M | 11.54M | 11.73M | 3.77M | 3.76M | 2.76M | 1.73M | 256.61K |
| OpEx % of Revenue | - | - | - | -249.78% | - | - | 129.12% | 1598.02% | 20320.75% | 317.1% | 1130.15% | 534.81% | 110.29% | 2466.67% | 1148.14% | 353.47% | 179.47% | 255.93% | 172.7% | 14.55% |
| Selling, General & Admin | 5.31M | 2.55M | 3.43M | 4.48M | 2.79M | 3.44M | 3.38M | 2.28M | 2.86M | 3.7M | 3.89M | 3.58M | 3.13M | 3.17M | 4.24M | 3.77M | 3.76M | 2.76M | 1.73M | 256.61K |
| SG&A % of Revenue | - | - | - | 89.78% | - | - | 48.34% | 646.18% | 5392.45% | 71.94% | 317.81% | 135.57% | 20.54% | 677.99% | 414.58% | 353.47% | 179.47% | 255.93% | 172.7% | 14.55% |
| Research & Development | 2.24M | 4.74M | 4.16M | 7.61M | 8.5M | 5.96M | 5.65M | 3.36M | 7.91M | 12.6M | 9.94M | 10.54M | 13.7M | 8.37M | 7.5M | 6.63M | 6.7M | 4.89M | 18.71M | 4.32M |
| R&D % of Revenue | - | - | - | 152.42% | - | - | 80.78% | 951.84% | 14928.3% | 245.16% | 812.34% | 399.24% | 89.75% | 1788.68% | 733.56% | 622.33% | 319.95% | 453.24% | 1871.2% | 245% |
| Other Operating Expenses | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -7.55M | -7.29M | -7.59M | -7.1M | -11.29M | -9.39M | -2.04M | -5.44M | -10.73M | -13.54M | -13.54M | -11.48M | -1.57M | -11.08M | -10.71M | -9.34M | -8.37M | -6.58M | -19.44M | -2.81M |
| Operating Margin % | - | - | - | -142.2% | - | - | -29.12% | -1541.64% | -20239.62% | -263.57% | -1106.13% | -434.81% | -10.29% | -2366.67% | -1048.14% | -875.8% | -399.43% | -609.17% | -1943.9% | -159.55% |
| Operating Income Growth % | 33.07% | 22.4% | -272.69% | -30.39% | -5.2% | 30.65% | 84.96% | 52.59% | -582.81% | -22.29% | -26.39% | -22.95% | 81.23% | -68.35% | 44.89% | -231.68% | - | -85.63% | -387.67% | - |
| EBITDA | -7.55M | -7.28M | -7.48M | -7.01M | -10.86M | -9.27M | -1.89M | -5.09M | -10.41M | -13.25M | -13.23M | -11.29M | -1.4M | -10.9M | -10.54M | -9.24M | -8.28M | -6.5M | -19.37M | -2.77M |
| EBITDA Margin % | - | - | - | -140.46% | - | - | -27.06% | -1441.93% | -19639.62% | -257.83% | -1080.56% | -427.65% | -9.19% | -2329.49% | -1031.7% | -866.79% | -395.27% | -602.04% | -1936.8% | -156.84% |
| EBITDA Growth % | 30.49% | 21.48% | -295.4% | -37.7% | -4.35% | 30.02% | 85.69% | 54.92% | -641.91% | -21.54% | -25.44% | -22.19% | 83.06% | -67.67% | 45.56% | -233.94% | - | -86.11% | -390.77% | - |
| D&A (Non-Cash Add-back) | 3K | 8K | 107K | 87K | 423K | 120K | 144K | 352K | 318K | 295K | 313K | 189K | 168K | 174K | 168K | 96K | 87K | 77K | 71K | 47.86K |
| EBIT | -7.18M | -8.57M | -3.13M | -3.2M | -11.29M | -8.09M | -409K | -3.65M | -10.73M | -13.54M | -13.54M | -11.48M | -1.57M | -11.08M | -10.71M | -9.34M | -8.37M | -6.58M | -19.44M | -2.81M |
| Net Interest Income | 537K | 607K | 584K | 817K | 805K | 811K | 810K | 846K | 809K | 698K | 617K | 471K | 39K | -90K | -163K | 0 | -158K | -187K | -129K | -126.8K |
| Interest Income | 537K | 607K | 713K | 1.33M | 805K | 811K | 810K | 846K | 809K | 698K | 617K | 471K | 39K | 0 | 0 | 0 | 158K | 0 | 0 | 97.35K |
| Interest Expense | 0 | 0 | 129K | 515K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 90K | 163K | 0 | 186.74K | 187K | 129K | 126.8K |
| Other Income/Expense | 371K | -1.28M | 4.33M | 3.51M | -915K | 1.18M | 1.5M | -995K | 1.94M | 942K | -330K | -3.37M | 2.55M | 3.05M | 949K | 1.17M | 1.48M | -1.43M | -279K | 204.4K |
| Pretax Income | -7.18M | -8.57M | -3.25M | -3.59M | -12.2M | -8.21M | -539K | -6.44M | -8.79M | -12.6M | -13.87M | -14.85M | 983K | -8.03M | -9.76M | -8.16M | -6.89M | -8.01M | -19.72M | -2.61M |
| Pretax Margin % | - | - | - | -71.94% | - | - | -7.71% | -1823.51% | -16577.36% | -245.24% | -1133.09% | -562.42% | 6.44% | -1715.81% | -955.28% | -765.67% | -328.83% | -741.2% | -1971.8% | -147.96% |
| Income Tax | 6K | 72K | 225K | 380K | 96K | 86K | 69K | 61K | 50K | 97K | 71K | 67K | 47K | 76K | 59K | 57K | 44K | 32K | 24K | 43K |
| Effective Tax Rate % | -0.08% | -0.84% | -6.91% | -10.58% | -0.79% | -1.05% | -12.8% | -0.95% | -0.57% | -0.77% | -0.51% | -0.45% | 4.78% | -0.95% | -0.6% | -0.7% | -0.64% | -0.4% | -0.12% | -1.65% |
| Net Income | -7.19M | -8.64M | -3.48M | -3.97M | -12.3M | -8.3M | -608K | -6.5M | -8.84M | -12.7M | -13.94M | -14.91M | 936K | -8.11M | -9.82M | -8.22M | -6.93M | -8.04M | -19.74M | -2.65M |
| Net Margin % | - | - | - | -79.56% | - | - | -8.7% | -1840.79% | -16671.7% | -247.13% | -1138.89% | -564.96% | 6.13% | -1732.05% | -961.06% | -771.01% | -330.93% | -744.17% | -1974.2% | -150.4% |
| Net Income Growth % | 41.54% | -4.08% | -472.2% | 38.9% | -39.16% | 34.65% | 95.64% | 56.43% | -1044.02% | -56.67% | -41.93% | -81.47% | 113.5% | -0.86% | 50.25% | -209.75% | - | -106.17% | -387.06% | - |
| Net Income (Continuing) | -7.19M | -8.64M | -3.48M | -3.97M | -12.3M | -8.3M | -608K | -6.5M | -8.84M | -12.7M | -13.94M | -14.91M | 936K | -8.11M | -9.82M | -8.22M | -6.93M | -8.04M | -19.74M | -2.65M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.27 | -0.32 | -0.13 | -0.14 | -0.46 | -0.31 | -0.02 | -0.24 | -0.34 | -0.48 | -0.53 | -0.57 | 0.04 | -0.31 | -0.38 | -0.32 | -0.27 | -0.31 | -0.77 | -9.44 |
| EPS Growth % | 41.3% | -3.23% | -531.07% | 41.67% | -35.29% | 35.42% | 96.11% | 57.89% | -1039.23% | -54.84% | -39.47% | -78.13% | 113.41% | 0% | 50.65% | 96.61% | - | 96.44% | 91.5% | - |
| EPS (Basic) | -0.27 | -0.32 | -0.13 | -0.14 | -0.46 | -0.31 | -0.02 | -0.24 | -0.34 | -0.48 | -0.53 | -0.57 | 0.04 | -0.31 | -0.38 | -0.32 | -0.27 | -0.31 | -0.77 | -9.44 |
| Diluted Shares Outstanding | 26.9M | 26.9M | 26.89M | 26.87M | 26.85M | 26.82M | 26.79M | 26.77M | 26.29M | 26.29M | 26.29M | 26.29M | 26.45M | 25.78M | 25.78M | 25.78M | 25.78M | 25.52M | 25.52M | 25.52M |
| Basic Shares Outstanding | 26.9M | 26.9M | 26.89M | 26.87M | 26.85M | 26.82M | 26.79M | 26.77M | 26.29M | 26.29M | 26.29M | 26.29M | 25.85M | 25.78M | 25.78M | 25.78M | 25.68M | 25.52M | 25.52M | 25.52M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |